Literature DB >> 29388792

Transcription factor GATA6: a novel marker and putative inducer of ductal metaplasia in biliary atresia.

Tea Soini1, Marjut Pihlajoki1,2, Noora Andersson1, Jouko Lohi3, Kari A Huppert4, David A Rudnick2,5, Stacey S Huppert4,5, David B Wilson2,6, Mikko P Pakarinen1,7, Markku Heikinheimo1,2.   

Abstract

Biliary atresia (BA), a neonatal liver disease, is characterized by obstruction of extrahepatic bile ducts with subsequent cholestasis, inflammation, and progressive liver fibrosis. To gain insights into the pathophysiology of BA, we focused attention on GATA6, a transcription factor implicated in biliary development. Early in fetal development GATA6 expression is evident in cholangiocytes and hepatocytes, but by late gestation it is extinguished in hepatocytes. Utilizing a unique set of BA liver samples collected before and after successful portoenterostomy (PE), we found that GATA6 expression is markedly upregulated in hepatocytes of patients with BA compared with healthy and cholestatic disease controls. This upregulation is recapitulated in two murine models simulating bile duct obstruction and intrahepatic bile ductule expansion. GATA6 expression in BA livers correlates with two established negative prognostic indicators (age at PE, degree of intrahepatic bile ductule expansion) and decreases after normalization of serum bilirubin by PE. GATA6 expression in BA livers correlates with expression of known regulators of cholangiocyte differentiation ( JAGGED1, HNF1β, and HNF6). These same genes are upregulated after enforced expression of GATA6 in human hepatocyte cell models. In conclusion, GATA6 is a novel marker and a putative driver of hepatocyte-cholangiocyte metaplasia in BA, and its expression in hepatocytes is downregulated after successful PE. NEW & NOTEWORTHY A pathological hallmark in the liver of patients with biliary atresia is ductular reaction, an expansion of new bile ductules that are thought to arise from conversion of mature hepatocytes. Here, we show that transcription factor GATA6 is a marker and potential driver of hepatocyte ductal metaplasia in biliary atresia. Hepatocyte GATA6 expression is elevated in biliary atresia, correlates with bile duct expansion, and decreases after successful portoenterostomy.

Entities:  

Keywords:  cholestasis; ductular reaction; hepatocyte transdifferentiation; transcriptional regulation

Mesh:

Substances:

Year:  2018        PMID: 29388792      PMCID: PMC6008062          DOI: 10.1152/ajpgi.00362.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  46 in total

1.  Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects.

Authors:  Sarbjit S Nijjar; Lorraine Wallace; Heather A Crosby; Stefan G Hubscher; Alastair J Strain
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

3.  GATA Transcription Factors and Cancer.

Authors:  Rena Zheng; Gerd A Blobel
Journal:  Genes Cancer       Date:  2010-12

4.  GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm.

Authors:  E E Morrisey; H S Ip; M M Lu; M S Parmacek
Journal:  Dev Biol       Date:  1996-07-10       Impact factor: 3.582

5.  Genetic interactions between hepatocyte nuclear factor-6 and Notch signaling regulate mouse intrahepatic bile duct development in vivo.

Authors:  Charles Vanderpool; Erin E Sparks; Kari A Huppert; Maureen Gannon; Anna L Means; Stacey S Huppert
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

6.  Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening.

Authors:  Marie-Odile Serinet; Barbara E Wildhaber; Pierre Broué; Alain Lachaux; Jacques Sarles; Emmanuel Jacquemin; Frédéric Gauthier; Christophe Chardot
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

7.  Characterization of time-related changes after experimental bile duct ligation.

Authors:  P Georgiev; W Jochum; S Heinrich; J H Jang; A Nocito; F Dahm; P-A Clavien
Journal:  Br J Surg       Date:  2008-05       Impact factor: 6.939

8.  The role of Notch receptor expression in bile duct development and disease.

Authors:  Diana M Flynn; Sarbjit Nijjar; Stefan G Hubscher; Jean de Ville de Goyet; Deirdre A Kelly; Alastair J Strain; Heather A Crosby
Journal:  J Pathol       Date:  2004-09       Impact factor: 7.996

Review 9.  Biliary atresia.

Authors:  Jane L Hartley; Mark Davenport; Deirdre A Kelly
Journal:  Lancet       Date:  2009-11-14       Impact factor: 79.321

10.  Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa.

Authors:  Hanna Haveri; Mia Westerholm-Ormio; Katri Lindfors; Markku Mäki; Erkki Savilahti; Leif C Andersson; Markku Heikinheimo
Journal:  BMC Gastroenterol       Date:  2008-04-11       Impact factor: 3.067

View more
  7 in total

1.  Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors.

Authors:  Ulla-Maija Haltia; Marjut Pihlajoki; Noora Andersson; Lotta Mäkinen; Johanna Tapper; Alejandra Cervera; Hugo M Horlings; Ursula Turpeinen; Mikko Anttonen; Ralf Bützow; Leila Unkila-Kallio; Olli Carpén; David B Wilson; Markku Heikinheimo; Anniina Färkkilä
Journal:  J Endocr Soc       Date:  2020-03-16

2.  Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.

Authors:  Lin He; Dennis Kai Ming Ip; Greta Tam; Vincent Chi Hang Lui; Paul Kwong Hang Tam; Patrick Ho Yu Chung
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 3.  Role of Immune Cells in Biliary Repair.

Authors:  Tian Lan; Shuaijie Qian; Chengwei Tang; Jinhang Gao
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 4.  Biliary Atresia Animal Models: Is the Needle in a Haystack?

Authors:  Nutan Pal; Parijat S Joy; Consolato M Sergi
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

5.  Evolving Up-regulation of Biliary Fibrosis-Related Extracellular Matrix Molecules After Successful Portoenterostomy.

Authors:  Antti Kyrönlahti; Nimish Godbole; Oyediran Akinrinade; Tea Soini; Iiris Nyholm; Noora Andersson; Maria Hukkinen; Jouko Lohi; David B Wilson; Marjut Pihlajoki; Mikko P Pakarinen; Markku Heikinheimo
Journal:  Hepatol Commun       Date:  2021-02-09

6.  Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers.

Authors:  Charles E Mordaunt; Dorothy A Kieffer; Noreene M Shibata; Anna Członkowska; Tomasz Litwin; Karl-Heinz Weiss; Yihui Zhu; Christopher L Bowlus; Souvik Sarkar; Stewart Cooper; Yu-Jui Yvonne Wan; Mohamed R Ali; Janine M LaSalle; Valentina Medici
Journal:  Epigenetics Chromatin       Date:  2019-02-01       Impact factor: 4.954

7.  Single-cell omics analysis reveals functional diversification of hepatocytes during liver regeneration.

Authors:  Tianyi Chen; Sehhoon Oh; Simon Gregory; Xiling Shen; Anna Mae Diehl
Journal:  JCI Insight       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.